MILBEMAX FILM COATED TABLETS FOR CATS

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Buy It Now

Active ingredient:

MILBEMYCIN OXIME PRAZIQUANTEL

Available from:

Novartis Animal Health UK Ltd

ATC code:

QP54AB51

Pharmaceutical form:

Coated Tablets

Therapeutic group:

Endoparasiticide

Therapeutic area:

Feline

Authorization date:

2009-06-01

Summary of Product characteristics

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Milbemax
Film-coated tablets for cats
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Excipients QS one divisable tablet of 132.5 mg
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Film-coated tablet
Oblong shaped, reddish to reddish brown, artificial beef flavoured tablets with a score on both sides.
One side bears the imprint “KK”, the other side “NA”. 
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In cats: treatment of mixed infections by immature and adult cestodes AND nematodes of the following species :
- Cestodes:
_Dipylidium caninum_
_Taenia spp._
_Echinococcus multilocularis_
- Nematodes:
_Ancylostoma tubaeforme_
_Toxocara cati_
Prevention of heartworm disease (Dirofilaria immitis) if concomitant treatment against cestodes is indicated.
4.3 CONTRAINDICATIONS
Do not use in cats weighing less than 2 kg.
Each tablet contains:
Active substances:
Milbemycin oxime
16 mg
Praziquantel
40 mg
Excipients:
Iron oxide (E172)
0.288 mg
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 23/05/2011_
_CRN 7010359_
_page number: 1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
As per good veterinary practice, animals should be weighed to ensure accurate dosing.
Echinococcosis represents a hazard for humans. In case of Echinococcosis, specific
guidelines on the treatment and follow up and on the safeguard of persons have to be followed. Experts or institutes of
parasitology should be consulted.
No studies have been performed with severely debilitated cats or individuals with seriously compromised
                                
                                Read the complete document